Primary cutaneous T-cell lymphoma is rare. Cutaneous lymphoma is defined as primary when there is an absence of nodal or systemic disease during the first 6 months following diagnosis. We report what we believe to be the first documented case of a primary cutaneous CD30positive anaplastic large-cell lymphoma of the external auditory canal. The patient was an elderly woman who presented with progressively worsening right otalgia and hypoacusis. Otoscopy revealed an erythematic, ulcerative, nonbleeding, localized lesion in the anterosuperior area of the external auditory canal. The patient underwent an excisional biopsy, and after the diagnosis was established, she underwent 22 sessions of radiotherapy. During followup, she exhibited no evidence of recurrence.
Introduction
Primary cutaneous T-cell lymphoma is a rare form of non-Hodgkin lymphoma. At the time of diagnosis, extracutaneous extension is usually not present. Approximately 20% of all non-Hodgkin lymphomas originate in T lymphocytes. 1 The skin is the second most frequently involved extraganglionic site of non-Hodgkin lymphoma. According to the world literature, the incidence of skin involvement ranges from 0.5 to 2.0 per 100,000 population. 2 A cutaneous lymphoma is classified as primary if no nodal or systemic involvement is observed within 6 months after the diagnosis. 3 The most common form of primary T-cell lymphoma is mycosis fungoides, which represents 50% of all cutaneous non-Hodgkin lymphomas; its annual incidence in the United States is 0.29 per 100,000 population. 4 The second most common form is cutaneous CD30-positive T-cell lymphoma, which accounts for 25 to 30% of all cases. 5 Cutaneous CD30-positive T-cell lymphoma comprises a group of pathologies that includes lymphomatoid papulosis, primary cutaneous anaplastic large-cell lymphoma, and borderline lesions. In this article, we report a new case.
Case report
A 68-year-old woman with a history of arterial hypertension, dyslipidemia, osteoarthritis, and chronic vertigo presented to her primary care physician complaining of progressively worsening right otalgia and hypoacusis. She reported no history of relevant trauma or fever. She was diagnosed with cerumen accumulation and medicated with paradichlorobenzene ear drops.
A few months later, her symptoms not only persisted but became aggravated by the onset of pruritus and fetid otorrhea. She returned to her physician and was diagnosed with otitis externa and treated with ciprofloxacin at 500 mg twice daily for 8 days. One year later, she began to experience hematic otorrhea, and she was referred to the Department of Otorhinolaryngology at the São Marcos Hospital in Braga, Portugal.
At our institution, the patient related no history of cancer, diabetes mellitus, or other immunosuppressive condition. Right otoscopy detected an erythematic, ulcerative, friable, localized lesion in the anterosuperior area of the external auditory canal. The lesion was soft in consistency, and its dimensions were irregular. It was not actively bleeding. The mass had caused a subtotal stenosis of the external auditory canal. It had also produced a Laboratory tests-including hepatic function, complete blood count, biochemistry, and inflammation indicators-were normal. The hematocrit value was 39.5%, and the hemoglobin level was 13.2 g/dl.
Computed tomography (CT) of the right ear identified a 20 × 12-mm mass in the external auditory canal (figure 1). The mass had thinned the subcutaneous planes, but it had not caused any osseous erosion. Medially, the mass extended to the superior edge of the tympanic membrane. There was no extension into the middle ear.
An excisional biopsy of the lesion was performed with local anesthesia. Histologic examination identified various fragments of focally ulcerated dermis and epidermis that contained extensive heterogeneous lymphoid cells-some small and some large-dispersed throughout the sample. An immunohistochemical study of this cellular population revealed positive staining of the large cells for CD3, CD5, CD30, and Ki-67 and negative staining for CD20, CD79a, bcl-2, myeloperoxidase, anaplastic lymphoma kinase (ALK), cyclin D1, CD56, perforin, granzyme B, and MNF-116. Also, a few dispersed small B lymphocytes were observed on CD20 and CD79a staining.
Soon after, thoracic and abdominal CT and a bone marrow biopsy were performed; neither revealed any anomaly. Hence, the patient was diagnosed with primary cutaneous CD30-positive anaplastic large-cell lymphoma of the external auditory canal. She underwent 22 sessions of irradiation to the right external auditory canal with 39.6 Gy at 6 MV. At the 6-month follow-up, she remained free of both local (figure 2) and systemic disease. She remained on regular follow-up in both the ENT and oncology departments.
Discussion
Cutaneous T-cell lymphoma seldom occurs in the temporal bone. 6 Primary cutaneous CD30-positive T-cell lymphoma typically presents as a single or multiple, medium-sized to large, reddish nodule or tumor that may initially undergo temporary regression only to persist later. This tumor is more common in adults than in children and adolescents.
Morphologically, primary T-cell lymphoma lesions exhibit a grossly nodular and/or diffuse pattern of dermal involvement with frequent extension to the subcutis. The cell population typically consists of large anaplastic cells grouped in large, confluent, cohesive sheets. 7 The histologic gold standard for establishing a diagnosis of primary cutaneous CD30-positive T-cell lymphoma is positive staining for CD30 in at least 75% of the lymphoma cells. 8 The clinical differential diagnosis in our case included a foreign-body granuloma, otitis externa, hemangioma, and squamous cell carcinoma among other possibilities. Because this tumor presents as a nonspecific cutaneous lesion, only a biopsy can determine its true nature.
The prognosis is favorable in most cases, with a reported 10-year survival rate of more than 90%. 9 Patients with ALK-positive anaplastic large-cell lymphoma have a better prognosis than those with an ALK-negative tumor, but the reason for the difference in survival is unknown. 10 Regional lymph node involvement is rare; when it does occur, it does not appear to adversely affect the prognosis.
Radiotherapy is mainly indicated when complete surgical removal is not possible. However, some authors advocate radiotherapy as the treatment of choice because primary cutaneous CD30-positive T-cell lymphoma is an indolent, radiosensitive tumor. 11 Chemotherapy is reserved for those patients with multifocal or generalized skin involvement (20% of patients) and for those with visceral spread (10%). 12 We believe this is the first reported case of a primary cutaneous CD30-positive anaplastic large-cell lymphoma of the external auditory canal. Furthermore, we deem this case to be of relevance in view of the diagnostic difficulty involved.
